Washington State Convention Center | Seattle
April 2-6 | Exhibit Dates: April 3-5
April 6 | ACMG/SIMD Joint Session

BioMarin Pharmaceutical Inc.

Novato,  CA 
United States
http://www.bmrn.com
  • Booth: 500

Profile

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. Approved products include the first and only therapies for PKU, LEMS, MPS I, MPS VI, MPS IVA, and CLN2 disease. Clinical development programs include investigational therapies for Hemophilia A, Achondroplasia, MPS IIIB, Friedreich’s Ataxia and other rare diseases.